Who Can Participate?
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
A Managed Access Protocol for Patients with Advanced Solid Tumors who have Completed Protocol XTX101-01/02-001 (NCT04896697) Monotherapy Vilastobart (XTX101) and/or Combination Therapy Vilastobart and Atezolizumab and Continue to Receive Benefit from Treatment
Principal Investigator
Nicholas
DeVito
Protocol Number
PRO00120304
Phase
N/A
Enrollment Status
Open to Enrollment